Henri Mondor hospital
Créteil, Creteil, 94010, France
NCT Number: NCT06699017
Intro:
The mortality of acute respiratory distress syndrome (ARDS) remains high (40%), and may be aggravated by ventilation-induced lung injury (VILI), the main mechanisms of which are:
1. Anterior region overdistension, 2. Atelectrauma in the posterior regions. Positive expiratory pressure (PEEP) adjusted on the ventilator during ARDS aims to recruit posterior pulmonary territories in order to limit atelectrauma but is accompanied by a concomitant risk of overdistension of anterior territories.
Recent data suggest that continuous anterior chest compression (CACC) could limit the overdistension of the anterior regions by decreasing the compliance of the anterior chest wall and thus the regional transpulmonary pressure, while promoting the redistribution of ventilation to the posterior territories.
The effects of CCAC on ventilation/perfusion ratios and hemodynamics are unknown.
Hypothesis/Objective :
The participants hypothesize that during ARDS, CCAC:
1. Improves ventilation/perfusion ratios by decreasing both anterior territory dead space effect and posterior territory shunt, 2. Induce an improvement in cardiac output by decreasing right ventricular afterload (decrease in capillary compression related to the overdistension of the anterior territories and decrease in hypoxic vasoconstriction of the condensed territories).
Objective:
Primary outcome :
To evaluate the effects of CCAC on ventilation/perfusion ratios during moderate to severe ARDS.
Secondary outcome :
To evaluate the effects of CCAC on hemodynamics : left heart morphology, systolic and diastolic function, cardiac output, right heart morphology, systolic function, pulmonary hypertension, volemia.
Method In patient with moderate to severe ARDS, CACC is performed manually and the pressure applied will be maintained between 60 and 80 cmH2O.
Electrical impedance tomography of ventilation and perfusion will be used for the measurement of the percentage of areas with normal VA/Q ratios, areas of shunt and areas of dead space effect.
Left heart morphology, systolic and diastolic function, cardiac output, right heart morphology, systolic function, pulmonary hypertension, volemia will be evaluated by using echocardiography.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Créteil, Creteil, 94010, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CACC is performed manually and the pressure applied will be maintained between 60 and 80 cmH2O.
Time frame: 28 days
demonstration that CACC may improve VA/Q ratio by using electrical impedance tomography
Time frame: 28 days
measurement of cardiac output with echocardiography via : left ventricle outflow tract velocity time integral cm)
Time frame: 28 days
RV/LV : right ventricle end-diastolic ratio, to LV end-diastolic diameter ratio, sLV eccentricity index : systolic left ventricle eccentricity index; ACP : Acute cor pulmonale
Time frame: 28 days
measurement of right systolic function paramaters : TAPSE (mm) , S' annular tricuspid wave (m/s), RVFAC (%)
Time frame: 28 days
LVEF : left ventricular ejection fraction
Time frame: 28 days
ventilation distribution antero-posterior and right/left, assessed by electrical impedance tomography
Time frame: 28 days
lung perfusion distribution antero-posterior and right/left assessed by electrical impedance tomography
Assistance Publique - Hôpitaux de Paris
Other
Evaluation of the Effects of Continuous Anterior Chest Compression on Ventilation/Perfusion Ratios and Hemodynamics in SDRA
Acronym: HemodyCACC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05825534
Acute Lung Injury, Acute Respiratory Distress Syndrome
Amiens, France
View Trial DetailsNCT05930418
Acute Respiratory Distress Syndrome, Cardiovascular Diseases
Memphis, Tennessee, United States
View Trial DetailsNCT03799874
Acute Respiratory Distress Syndrome, Lung Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT05894291
Acute Respiratory Distress Syndrome, Lung Diseases
Orléans, France
View Trial Details